Queen Mary’s Barts Cancer Institute co-leads £43.6m initiative to accelerate AI-powered cancer breakthroughs
11th February 2025
Barts Cancer Institute, Queen Mary University of London will co-lead a ground-breaking collaboration, PharosAI, that aims to harness cutting-edge artificial intelligence (AI) and unlock decades of NHS cancer data. The UK government is committing £18.9 million to the project.
Read more
Barts Cancer Institute book celebrates two decades of cancer discovery
4th February 2025
Barts Cancer Institute, Queen Mary Univerity of London, is delighted to announce the publication of a special commemorative book celebrating twenty years of cancer discoveries since the establishment of the institute.
Read more
Professor Louise Jones wins Goudie Medal for excellence in pathology
22nd January 2025
Professor Louise Jones has been awarded the Pathological Society’s prestigious Goudie Medal for her seminal contributions to pathological science and understanding of disease.
Read more
Protein level predicts immunotherapy response in bowel cancer
16th January 2025
Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.
Read more
Discovery of lingering DNA damage could change our understanding of cancer development
15th January 2025
Dr Michael Spencer Chapman and team have uncovered forms of DNA damage in healthy cells that can persist unrepaired for years
Read more
Surprising ‘two-faced’ cancer gene role supports paradigm shift in predicting disease
3rd January 2025
A genetic fault long believed to drive the development of oesophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer.
Read more